đŸ“£ Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Amicus Therapeutics Inc

Common Name
Amicus Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
499
Ticker
FOLD
Exchange
NASDAQ/NMS
Description
Amicus Therapeutics Inc. is a biopharmaceutical company dedicated to developing advanced therapies for rare and orphan diseases. Its primary focus is on genetic disorders, particularly lysosomal stora...

Disclosures of Amicus Therapeutics

Explore Amicus Therapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Amicus Therapeutics's official channels and fully traceable to its official company sources.

The table below lists all of Amicus Therapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
ESG Report2024
Financial & Extra-Financial Disclosure2024
10-K2024
Financial & Extra-Financial Disclosure2023
10-K2023
ESG Report2023
Annual Report2023
10-K2022
ESG Report2022
10-K2021
ESG Report2021
Financial Report2021
ESG Data Spreadsheet2021
10-K2020
ESG Data Spreadsheet2020
Financial Report2020
10-K2019
Financial Report2019
10-K2018
ESG Data Spreadsheet2018
10-K2017
ESG Data Spreadsheet2017
10-K2016
ESG Data Spreadsheet2016
10-K2015
10-K2014
10-K2013
10-K2012
10-K2011
10-K2010
10-K2009
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?